These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22456094)
1. Does antidepressant treatment improve cognition in older people with schizophrenia or schizoaffective disorder and comorbid subsyndromal depression? Dawes SE; Palmer BW; Meeks T; Golshan S; Kasckow J; Mohamed S; Zisook S Neuropsychobiology; 2012; 65(3):168-72. PubMed ID: 22456094 [TBL] [Abstract][Full Text] [Related]
2. Citalopram augmentation for subsyndromal symptoms of depression in middle-aged and older outpatients with schizophrenia and schizoaffective disorder: a randomized controlled trial. Zisook S; Kasckow JW; Golshan S; Fellows I; Solorzano E; Lehman D; Mohamed S; Jeste DV J Clin Psychiatry; 2009 Apr; 70(4):562-71. PubMed ID: 19192468 [TBL] [Abstract][Full Text] [Related]
3. Treatment of subsyndromal depressive symptoms in middle-aged and older adults with schizophrenia: effect on functioning. Kasckow J; Lanouette N; Patterson T; Fellows I; Golshan S; Solorzano E; Zisook S Int J Geriatr Psychiatry; 2010 Feb; 25(2):183-90. PubMed ID: 19711335 [TBL] [Abstract][Full Text] [Related]
4. Subsyndromal depressive symptoms in middle-aged and older persons with schizophrenia. Zisook S; Montross L; Kasckow J; Mohamed S; Palmer BW; Patterson TL; Golshan S; Fellows I; Lehman D; Solorzano E Am J Geriatr Psychiatry; 2007 Dec; 15(12):1005-14. PubMed ID: 18056819 [TBL] [Abstract][Full Text] [Related]
5. Adding antidepressants to antipsychotics for treatment of subsyndromal depressive symptoms in schizophrenia: Impact on positive and negative symptoms. Vahia IV; Lanouette NM; Golshan S; Fellows I; Mohamed S; Kasckow JW; Zisook S Indian J Psychiatry; 2013 Apr; 55(2):144-8. PubMed ID: 23825848 [TBL] [Abstract][Full Text] [Related]
6. A double blind, placebo-controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression. Holtzheimer PE; Meeks TW; Kelley ME; Mufti M; Young R; McWhorter K; Vito N; Chismar R; Quinn S; Dey S; Byrd EH; McDonald WM Int J Geriatr Psychiatry; 2008 Jun; 23(6):625-31. PubMed ID: 18058832 [TBL] [Abstract][Full Text] [Related]
7. Augmentation with citalopram for suicidal ideation in middle-aged and older outpatients with schizophrenia and schizoaffective disorder who have subthreshold depressive symptoms: a randomized controlled trial. Zisook S; Kasckow JW; Lanouette NM; Golshan S; Fellows I; Vahia I; Mohamed S; Rao S J Clin Psychiatry; 2010 Jul; 71(7):915-22. PubMed ID: 20361918 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. Keefe RS; Malhotra AK; Meltzer HY; Kane JM; Buchanan RW; Murthy A; Sovel M; Li C; Goldman R Neuropsychopharmacology; 2008 May; 33(6):1217-28. PubMed ID: 17625502 [TBL] [Abstract][Full Text] [Related]
9. Treatment of subsyndromal depressive symptoms in middle-age and older patients with schizophrenia: effect of age on response. Kasckow J; Fellows I; Golshan S; Solorzano E; Meeks T; Zisook S Am J Geriatr Psychiatry; 2010 Sep; 18(9):853-7. PubMed ID: 20808103 [TBL] [Abstract][Full Text] [Related]
10. Co-occurring depressive symptoms in the older patient with schizophrenia. Kasckow JW; Zisook S Drugs Aging; 2008; 25(8):631-47. PubMed ID: 18665657 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Raskin J; Wiltse CG; Siegal A; Sheikh J; Xu J; Dinkel JJ; Rotz BT; Mohs RC Am J Psychiatry; 2007 Jun; 164(6):900-9. PubMed ID: 17541049 [TBL] [Abstract][Full Text] [Related]
12. The effect of adjunctive armodafinil on cognitive performance and psychopathology in antipsychotic-treated patients with schizophrenia/schizoaffective disorder: a randomized, double-blind, placebo-controlled trial. Bobo WV; Woodward ND; Sim MY; Jayathilake K; Meltzer HY Schizophr Res; 2011 Aug; 130(1-3):106-13. PubMed ID: 21641776 [TBL] [Abstract][Full Text] [Related]
13. Depressive symptom patterns in patients with chronic schizophrenia and subsyndromal depression. Zisook S; Nyer M; Kasckow J; Golshan S; Lehman D; Montross L Schizophr Res; 2006 Sep; 86(1-3):226-33. PubMed ID: 16750346 [TBL] [Abstract][Full Text] [Related]
14. Antidepressant Controlled Trial For Negative Symptoms In Schizophrenia (ACTIONS): a double-blind, placebo-controlled, randomised clinical trial. Barnes TR; Leeson VC; Paton C; Costelloe C; Simon J; Kiss N; Osborn D; Killaspy H; Craig TK; Lewis S; Keown P; Ismail S; Crawford M; Baldwin D; Lewis G; Geddes J; Kumar M; Pathak R; Taylor S Health Technol Assess; 2016 Apr; 20(29):1-46. PubMed ID: 27094189 [TBL] [Abstract][Full Text] [Related]
15. Combined treatment with memantine/es-citalopram for older depressed patients with cognitive impairment: a pilot study. Pelton GH; Harper OL; Roose SP; Marder K; D'Antonio K; Devanand DP Int J Geriatr Psychiatry; 2016 Jun; 31(6):648-55. PubMed ID: 26559790 [TBL] [Abstract][Full Text] [Related]
16. Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone. Harvey PD; Ogasa M; Cucchiaro J; Loebel A; Keefe RS Schizophr Res; 2011 Apr; 127(1-3):188-94. PubMed ID: 21277745 [TBL] [Abstract][Full Text] [Related]
17. Executive dysfunction, heart disease burden, and remission of geriatric depression. Alexopoulos GS; Kiosses DN; Murphy C; Heo M Neuropsychopharmacology; 2004 Dec; 29(12):2278-84. PubMed ID: 15340393 [TBL] [Abstract][Full Text] [Related]
18. Citalopram, methylphenidate, or their combination in geriatric depression: a randomized, double-blind, placebo-controlled trial. Lavretsky H; Reinlieb M; St Cyr N; Siddarth P; Ercoli LM; Senturk D Am J Psychiatry; 2015 Jun; 172(6):561-9. PubMed ID: 25677354 [TBL] [Abstract][Full Text] [Related]
19. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. de la Serna E; Andrés-Perpiñá S; Puig O; Baeza I; Bombin I; Bartrés-Faz D; Arango C; Gonzalez-Pinto A; Parellada M; Mayoral M; Graell M; Otero S; Guardia J; Castro-Fornieles J Schizophr Res; 2013 Jan; 143(1):125-31. PubMed ID: 23182439 [TBL] [Abstract][Full Text] [Related]
20. Repetitive transcranial magnetic stimulation in combination with citalopram in young patients with first-episode major depressive disorder: a double-blind, randomized, sham-controlled trial. Huang ML; Luo BY; Hu JB; Wang SS; Zhou WH; Wei N; Hu SH; Xu Y Aust N Z J Psychiatry; 2012 Mar; 46(3):257-64. PubMed ID: 22391283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]